Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 827.00
+6.00 (0.73%)
Oct 6, 2026, 10:41 AM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.23 billion as of October 6, 2026. Its market cap has decreased by -46.99% in one year.
Market Cap
4.23B
Enterprise Value
3.68B
Revenue
4.69B
Ranking
n/a
PE Ratio
33.03
Stock Price
827.00
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.23B, a decrease of -64.43%. That is a compound annual growth rate of -34.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.23B | -44.46% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |
| Transgenic Group | 4.06B |